These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6316224)

  • 1. Modulation of tumor cell adherence by prostaglandins.
    Fantone JC; Elgas LJ; Weinberger L; Varani J
    Oncology; 1983; 40(6):421-6. PubMed ID: 6316224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phorbol myristate acetate-induced adherence of Walker 256 carcinosarcoma cells.
    Varani J; Fantone JC
    Cancer Res; 1982 Jan; 42(1):190-7. PubMed ID: 7053849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotaxis of metastatic tumor cells.
    Varani J
    Cancer Metastasis Rev; 1982; 1(1):17-28. PubMed ID: 7185418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification and morphologic demonstration of reactive oxygen species produced by Walker 256 tumor cells in vitro and during metastasis in vivo.
    Soares FA; Shaughnessy SG; MacLarkey WR; Orr FW
    Lab Invest; 1994 Oct; 71(4):480-9. PubMed ID: 7967504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between chemotaxis, chemotactic modulators, and cyclic nucleotide levels in tumor cells.
    Mokashi S; Delikatny SJ; Orr FW
    Cancer Res; 1983 May; 43(5):1980-3. PubMed ID: 6299536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of PGE1-induced increase in cyclic AMP by chemotactic peptide and Ca2+ ionophore through calmodulin-dependent processes.
    Ishitoya J; Takenawa T
    J Immunol; 1987 Feb; 138(4):1201-7. PubMed ID: 2433345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulus specificity of prostaglandin inhibition of rabbit polymorphonuclear leukocyte lysosomal enzyme release and superoxide anion production.
    Fantone JC; Marasco WA; Elgas LJ; Ward PA
    Am J Pathol; 1984 Apr; 115(1):9-16. PubMed ID: 6324595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual effects of formylpeptides on the adhesion of endotoxin-primed human neutrophils.
    Bellavite P; Chirumbolo S; Lippi G; Andrioli G; Bonazzi L; Ferro I
    Cell Biochem Funct; 1993 Dec; 11(4):231-9. PubMed ID: 7903912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prostaglandin paradox: additive inhibition of neutrophil function by aspirin-like drugs and the prostaglandin E1 analog misoprostol.
    Kitsis EA; Weissmann G; Abramson SB
    J Rheumatol; 1991 Oct; 18(10):1461-5. PubMed ID: 1662723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phorbol myristate acetate (PMA) suppresses polarization and locomotion and alters F-actin content of Walker carcinosarcoma cells.
    Keller HU; Zimmermann A; Cottier H
    Int J Cancer; 1985 Oct; 36(4):495-501. PubMed ID: 4044057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phorbol ester-stimulated adherence of neutrophils to endothelial cells is reduced by adenosine A2 receptor agonists.
    Felsch A; Stöcker K; Borchard U
    J Immunol; 1995 Jul; 155(1):333-8. PubMed ID: 7602109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An assessment of the effects of glucocorticoids on degranulation, chemotaxis, binding to vascular endothelium and formation of leukotriene B4 by purified human neutrophils.
    Schleimer RP; Freeland HS; Peters SP; Brown KE; Derse CP
    J Pharmacol Exp Ther; 1989 Aug; 250(2):598-605. PubMed ID: 2547940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of prostaglandins on deoxyribonucleic acid and aggrecan synthesis in the RCJ 3.1C5.18 chondrocyte cell line: role of second messengers.
    Lowe GN; Fu YH; McDougall S; Polendo R; Williams A; Benya PD; Hahn TJ
    Endocrinology; 1996 Jun; 137(6):2208-16. PubMed ID: 8641167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Size increase induced in Walker ascites cells by chemotactic factors.
    Wass JA; Varani J; Ward PA
    Cancer Lett; 1980 Jun; 9(4):313-8. PubMed ID: 7397684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of formyl peptides to Walker 256 carcinosarcoma cells and the chemotactic response of these cells.
    Rayner DC; Orr FW; Shiu RP
    Cancer Res; 1985 May; 45(5):2288-93. PubMed ID: 3986773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissociation of neutrophil aggregation, adhesiveness, and Fc receptor activity.
    Spagnuolo PJ; Fain M; Bass SN
    Am J Hematol; 1987 Nov; 26(3):221-8. PubMed ID: 2445200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Various authentic chemoattractants mediating leukocyte adherence inhibition.
    Thomson DM
    J Natl Cancer Inst; 1984 Sep; 73(3):595-605. PubMed ID: 6088878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adhesion, chemotaxis, and aggregation of Walker carcinosarcoma cells in response to products of resorbing bone.
    Magro C; Orr FW; Manishen WJ; Sivananthan K; Mokashi SS
    J Natl Cancer Inst; 1985 Apr; 74(4):829-38. PubMed ID: 3857380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial cell damage by Walker carcinosarcoma cells is dependent on vitronectin receptor-mediated tumor cell adhesion.
    Shaughnessy SG; Lafrenie RM; Buchanan MR; Podor TJ; Orr FW
    Am J Pathol; 1991 Jun; 138(6):1535-43. PubMed ID: 1711295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of polymorphonuclear leukocyte adherence by prostacyclin.
    Boxer LA; Allen JM; Schmidt M; Yoder M; Baehner RL
    J Lab Clin Med; 1980 May; 95(5):672-8. PubMed ID: 6245158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.